Associate Director, Protein Sciences
D.Phil. in clinical medicine, University of Oxford. M.Biochem. in molecular and cellular biochemistry (co-terminus with undergraduate), University of Oxford
Prior to insitro, I led structural biology and the structure function team at Revolution Medicines, where I contributed tomultiple programs including SOS1 (RMC-5845) and the tri-complex RAS inhibitors RMC-6236 and RMC-6291 among others.
As head of protein sciences at insitro, I lead the team responsible for protein production, functional assays, biophysical assessment and structural biology. I am also a leader in insitro’s drug discovery projects.